March 6, 2025
Bad to worse
Just when you think things can’t get any worse, they do.
On March 3, the FDA updated a January recall for 912,119 total Medtronic MiniMed insulin pump. Additionally, it is now categorized as a Class II event, meaning the affected product “may cause temporary or medically reversible adverse health effects.”
Unfortunately, the bad news doesn’t stop there as word from Northridge is “they can’t get the damn thing to work.” This remark came from inside the company referring to the integration between the Abbott sensor and Medtronic platform. But this just might . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
